Human beta-glucuronidase: structure, function, and application in enzyme replacement therapy.

Article Details

Citation

Naz H, Islam A, Waheed A, Sly WS, Ahmad F, Hassan I

Human beta-glucuronidase: structure, function, and application in enzyme replacement therapy.

Rejuvenation Res. 2013 Oct;16(5):352-63. doi: 10.1089/rej.2013.1407.

PubMed ID
23777470 [ View in PubMed
]
Abstract

Lysosomal storage diseases occur due to incomplete metabolic degradation of macromolecules by various hydrolytic enzymes in the lysosome. Despite structural differences, most of the lysosomal enzymes share many common features including a lysosomal targeting motif and phosphotransferase recognition sites. beta-Glucuronidase (GUSB) is an important lysosomal enzyme involved in the degradation of glucuronate-containing glycosaminoglycan. The deficiency of GUSB causes mucopolysaccharidosis type VII (MPSVII), leading to lysosomal storage in the brain. GUSB is a well-studied protein for its expression, sequence, structure, and function. The purpose of this review is to summarize our current understanding of sequence, structure, function, and evolution of GUSB and its lysosomal enzyme targeting. Enzyme replacement therapy reported for this protein is also discussed.

DrugBank Data that Cites this Article

Drugs